反応式
[F:1][C:2]1[CH:3]=[C:4]([C:8]2[C:12]([CH2:13][OH:14])=[C:11]([CH3:15])[O:10][N:9]=2)[CH:5]=[CH:6][CH:7]=1.[H-].[Na+].Cl[C:19]1[CH:20]=[CH:21][C:22]2[N:23]([CH:25]=[N:26][N:27]=2)[N:24]=1.O>CN(C=O)C>[F:1][C:2]1[CH:3]=[C:4]([C:8]2[C:12]([CH2:13][O:14][C:19]3[CH:20]=[CH:21][C:22]4[N:23]([CH:25]=[N:26][N:27]=4)[N:24]=3)=[C:11]([CH3:15])[O:10][N:9]=2)[CH:5]=[CH:6][CH:7]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of [3-(3-fluoro-phenyl)-5-methyl-isoxazol-4-yl]-methanol (100 mg, 0.48 mmol) in DMF (2 mL) was added sodium hydride (55% dispersion in mineral oil, 23.2 mg, 0.53 mmol). The mixture was stirred at room temperature for 15 min. After addition of a solution of 6-chloro-1,2,4-triazolo[4,3-b]pyridazine (82 mg, 0.53 mmol) in DMF (3 mL) the mixture was stirred at room temperature overnight. Then the mixture was poured into water, extracted (ethyl acetate/water) and the organic phase was dried with sodium sulfate and concentrated. Chromatography (SiO2, heptane:ethyl acetate=100:0 to 9:1) afforded the title compound (80 mg, 51%) as a white solid. MS: m/e=326.0 [M+H]+.
後処理
- stirringwas stirred at room temperature overnight
- extractionextracted (ethyl acetate/water)
- dry with materialthe organic phase was dried with sodium sulfate
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-af8fc3c601894e38ac3ca4eff4f827ec
- 出典データセット
- uspto-grants-2011_05
- 特許番号
- US07943619B2
関連ノート
読み込み中…